Selected research
Market Structure
Global Saliva Drug and Alcohol Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Saliva Drug and Alcohol Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Saliva Drug and Alcohol Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Saliva Drug and Alcohol Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Saliva Drug and Alcohol Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Saliva Drug and Alcohol Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Saliva Drug and Alcohol Testing include Abbott, OraSure Technologies, Premier Biotech, Alcolizer, CareHealth America, AlphaBiolabs, AlcoDigital, VeriCheck and Azova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Saliva Drug and Alcohol Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Saliva Drug and Alcohol Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Saliva Drug and Alcohol Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Saliva Drug and Alcohol Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Saliva Drug and Alcohol Testing Segment by Company
Abbott
OraSure Technologies
Premier Biotech
Alcolizer
CareHealth America
AlphaBiolabs
AlcoDigital
VeriCheck
Azova
Draeger
Securetec Detektions-Systeme
Quest Diagnostics
Oranoxis
Salimetrics
Neogen Corporation
UCP Biosciences
Lin-Zhi International
MEDACX
AccuBioTech
Wondfo Biotech
Assure Tech
Express Medicals
Crystal Health
KINNECT
AusHealth
Dorevitch Pathology
Labcorp
Eurofins
Concentra
Bellin Health
Randox
MediNat
Clinical Labs
MHE
Awanui Labs
David Barber Occupational Health
SYNLAB
Test Smartly Labs
Cansford Laboratories
Medigold Health
PAM Group
Drugwise
Safework Health
Humanomics
CannAmm
Micro-Distributing
Saliva Drug and Alcohol Testing Segment by Type
On-Site Screening Products
Lab Testing
Saliva Drug and Alcohol Testing Segment by Application
Criminal Justice Testing
Workplace Testing
Rehabilitation Therapy
Others
Saliva Drug and Alcohol Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saliva Drug and Alcohol Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Saliva Drug and Alcohol Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saliva Drug and Alcohol Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Saliva Drug and Alcohol Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Saliva Drug and Alcohol Testing industry.
Chapter 3: Detailed analysis of Saliva Drug and Alcohol Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Saliva Drug and Alcohol Testingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-Site Screening Products
- Lab Testing
Applications
- Criminal Justice Testing
- Workplace Testing
- Rehabilitation Therapy
- Others
Companies covered
- Abbott
- OraSure Technologies
- Premier Biotech
- Alcolizer
- CareHealth America
- AlphaBiolabs
- AlcoDigital
- VeriCheck
- Azova
- Draeger
- Securetec Detektions-Systeme
- Quest Diagnostics
- Oranoxis
- Salimetrics
- Neogen Corporation
- UCP Biosciences
- Lin-Zhi International
- MEDACX
- AccuBioTech
- Wondfo Biotech
- Assure Tech
- Express Medicals
- Crystal Health
- KINNECT
- AusHealth
- Dorevitch Pathology
- Labcorp
- Eurofins
- Concentra
- Bellin Health
- Randox
- MediNat
- Clinical Labs
- MHE
- Awanui Labs
- David Barber Occupational Health
- SYNLAB
- Test Smartly Labs
- Cansford Laboratories
- Medigold Health
- PAM Group
- Drugwise
- Safework Health
- Humanomics
- CannAmm
- Micro-Distributing
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Saliva Drug and Alcohol Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 On-Site Screening Products
- 1.2.3 Lab Testing
- 1.3 Market Analysis by Application
- 1.3.1 Global Saliva Drug and Alcohol Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Criminal Justice Testing
- 1.3.3 Workplace Testing
- 1.3.4 Rehabilitation Therapy
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Saliva Drug and Alcohol Testing Growth Trends by Region
- 1.5.1 Global Saliva Drug and Alcohol Testing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Saliva Drug and Alcohol Testing Market Size by Region (2021-2026)
- 1.5.3 Saliva Drug and Alcohol Testing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Saliva Drug and Alcohol Testing Market Dynamics
- 2.1 Saliva Drug and Alcohol Testing Industry Trends
- 2.2 Saliva Drug and Alcohol Testing Industry Drivers
- 2.3 Saliva Drug and Alcohol Testing Industry Opportunities and Challenges
- 2.4 Saliva Drug and Alcohol Testing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Saliva Drug and Alcohol Testing Revenue by Company (2021-2026)
- 3.2 Global Saliva Drug and Alcohol Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Saliva Drug and Alcohol Testing Key Company Head office and Area Served
- 3.4 Global Saliva Drug and Alcohol Testing Company, Product Type & Application
- 3.5 Global Saliva Drug and Alcohol Testing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Saliva Drug and Alcohol Testing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Saliva Drug and Alcohol Testing Players Market Share by Revenue in 2025
- 3.6.3 2025 Saliva Drug and Alcohol Testing Tier 1, Tier 2, and Tier 3
4 Saliva Drug and Alcohol Testing Market by Type
- 4.1 Global Saliva Drug and Alcohol Testing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Saliva Drug and Alcohol Testing Market Size by Type (2021-2032)
- 4.3 Global Saliva Drug and Alcohol Testing Market Size Share by Type (2021-2032)
5 Saliva Drug and Alcohol Testing Market by Application
- 5.1 Global Saliva Drug and Alcohol Testing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Saliva Drug and Alcohol Testing Market Size by Application (2021-2032)
- 5.3 Global Saliva Drug and Alcohol Testing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Abbott Saliva Drug and Alcohol Testing Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 OraSure Technologies
- 6.2.1 OraSure Technologies Company Information
- 6.2.2 OraSure Technologies Business Overview
- 6.2.3 OraSure Technologies Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio
- 6.2.5 OraSure Technologies Recent Developments
- 6.3 Premier Biotech
- 6.3.1 Premier Biotech Company Information
- 6.3.2 Premier Biotech Business Overview
- 6.3.3 Premier Biotech Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio
- 6.3.5 Premier Biotech Recent Developments
- 6.4 Alcolizer
- 6.4.1 Alcolizer Company Information
- 6.4.2 Alcolizer Business Overview
- 6.4.3 Alcolizer Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Alcolizer Saliva Drug and Alcohol Testing Product Portfolio
- 6.4.5 Alcolizer Recent Developments
- 6.5 CareHealth America
- 6.5.1 CareHealth America Company Information
- 6.5.2 CareHealth America Business Overview
- 6.5.3 CareHealth America Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 CareHealth America Saliva Drug and Alcohol Testing Product Portfolio
- 6.5.5 CareHealth America Recent Developments
- 6.6 AlphaBiolabs
- 6.6.1 AlphaBiolabs Company Information
- 6.6.2 AlphaBiolabs Business Overview
- 6.6.3 AlphaBiolabs Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio
- 6.6.5 AlphaBiolabs Recent Developments
- 6.7 AlcoDigital
- 6.7.1 AlcoDigital Company Information
- 6.7.2 AlcoDigital Business Overview
- 6.7.3 AlcoDigital Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio
- 6.7.5 AlcoDigital Recent Developments
- 6.8 VeriCheck
- 6.8.1 VeriCheck Company Information
- 6.8.2 VeriCheck Business Overview
- 6.8.3 VeriCheck Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 VeriCheck Saliva Drug and Alcohol Testing Product Portfolio
- 6.8.5 VeriCheck Recent Developments
- 6.9 Azova
- 6.9.1 Azova Company Information
- 6.9.2 Azova Business Overview
- 6.9.3 Azova Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Azova Saliva Drug and Alcohol Testing Product Portfolio
- 6.9.5 Azova Recent Developments
- 6.10 Draeger
- 6.10.1 Draeger Company Information
- 6.10.2 Draeger Business Overview
- 6.10.3 Draeger Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Draeger Saliva Drug and Alcohol Testing Product Portfolio
- 6.10.5 Draeger Recent Developments
- 6.11 Securetec Detektions-Systeme
- 6.11.1 Securetec Detektions-Systeme Company Information
- 6.11.2 Securetec Detektions-Systeme Business Overview
- 6.11.3 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio
- 6.11.5 Securetec Detektions-Systeme Recent Developments
- 6.12 Quest Diagnostics
- 6.12.1 Quest Diagnostics Company Information
- 6.12.2 Quest Diagnostics Business Overview
- 6.12.3 Quest Diagnostics Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio
- 6.12.5 Quest Diagnostics Recent Developments
- 6.13 Oranoxis
- 6.13.1 Oranoxis Company Information
- 6.13.2 Oranoxis Business Overview
- 6.13.3 Oranoxis Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Oranoxis Saliva Drug and Alcohol Testing Product Portfolio
- 6.13.5 Oranoxis Recent Developments
- 6.14 Salimetrics
- 6.14.1 Salimetrics Company Information
- 6.14.2 Salimetrics Business Overview
- 6.14.3 Salimetrics Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Salimetrics Saliva Drug and Alcohol Testing Product Portfolio
- 6.14.5 Salimetrics Recent Developments
- 6.15 Neogen Corporation
- 6.15.1 Neogen Corporation Company Information
- 6.15.2 Neogen Corporation Business Overview
- 6.15.3 Neogen Corporation Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio
- 6.15.5 Neogen Corporation Recent Developments
- 6.16 UCP Biosciences
- 6.16.1 UCP Biosciences Company Information
- 6.16.2 UCP Biosciences Business Overview
- 6.16.3 UCP Biosciences Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio
- 6.16.5 UCP Biosciences Recent Developments
- 6.17 Lin-Zhi International
- 6.17.1 Lin-Zhi International Company Information
- 6.17.2 Lin-Zhi International Business Overview
- 6.17.3 Lin-Zhi International Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio
- 6.17.5 Lin-Zhi International Recent Developments
- 6.18 MEDACX
- 6.18.1 MEDACX Company Information
- 6.18.2 MEDACX Business Overview
- 6.18.3 MEDACX Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 MEDACX Saliva Drug and Alcohol Testing Product Portfolio
- 6.18.5 MEDACX Recent Developments
- 6.19 AccuBioTech
- 6.19.1 AccuBioTech Company Information
- 6.19.2 AccuBioTech Business Overview
- 6.19.3 AccuBioTech Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio
- 6.19.5 AccuBioTech Recent Developments
- 6.20 Wondfo Biotech
- 6.20.1 Wondfo Biotech Company Information
- 6.20.2 Wondfo Biotech Business Overview
- 6.20.3 Wondfo Biotech Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio
- 6.20.5 Wondfo Biotech Recent Developments
- 6.21 Assure Tech
- 6.21.1 Assure Tech Company Information
- 6.21.2 Assure Tech Business Overview
- 6.21.3 Assure Tech Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 Assure Tech Saliva Drug and Alcohol Testing Product Portfolio
- 6.21.5 Assure Tech Recent Developments
- 6.22 Express Medicals
- 6.22.1 Express Medicals Company Information
- 6.22.2 Express Medicals Business Overview
- 6.22.3 Express Medicals Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 Express Medicals Saliva Drug and Alcohol Testing Product Portfolio
- 6.22.5 Express Medicals Recent Developments
- 6.23 Crystal Health
- 6.23.1 Crystal Health Company Information
- 6.23.2 Crystal Health Business Overview
- 6.23.3 Crystal Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.23.4 Crystal Health Saliva Drug and Alcohol Testing Product Portfolio
- 6.23.5 Crystal Health Recent Developments
- 6.24 KINNECT
- 6.24.1 KINNECT Company Information
- 6.24.2 KINNECT Business Overview
- 6.24.3 KINNECT Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.24.4 KINNECT Saliva Drug and Alcohol Testing Product Portfolio
- 6.24.5 KINNECT Recent Developments
- 6.25 AusHealth
- 6.25.1 AusHealth Company Information
- 6.25.2 AusHealth Business Overview
- 6.25.3 AusHealth Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.25.4 AusHealth Saliva Drug and Alcohol Testing Product Portfolio
- 6.25.5 AusHealth Recent Developments
- 6.26 Dorevitch Pathology
- 6.26.1 Dorevitch Pathology Company Information
- 6.26.2 Dorevitch Pathology Business Overview
- 6.26.3 Dorevitch Pathology Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.26.4 Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio
- 6.26.5 Dorevitch Pathology Recent Developments
- 6.27 Labcorp
- 6.27.1 Labcorp Company Information
- 6.27.2 Labcorp Business Overview
- 6.27.3 Labcorp Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.27.4 Labcorp Saliva Drug and Alcohol Testing Product Portfolio
- 6.27.5 Labcorp Recent Developments
- 6.28 Eurofins
- 6.28.1 Eurofins Company Information
- 6.28.2 Eurofins Business Overview
- 6.28.3 Eurofins Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.28.4 Eurofins Saliva Drug and Alcohol Testing Product Portfolio
- 6.28.5 Eurofins Recent Developments
- 6.29 Concentra
- 6.29.1 Concentra Company Information
- 6.29.2 Concentra Business Overview
- 6.29.3 Concentra Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.29.4 Concentra Saliva Drug and Alcohol Testing Product Portfolio
- 6.29.5 Concentra Recent Developments
- 6.30 Bellin Health
- 6.30.1 Bellin Health Company Information
- 6.30.2 Bellin Health Business Overview
- 6.30.3 Bellin Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.30.4 Bellin Health Saliva Drug and Alcohol Testing Product Portfolio
- 6.30.5 Bellin Health Recent Developments
- 6.31 Randox
- 6.31.1 Randox Company Information
- 6.31.2 Randox Business Overview
- 6.31.3 Randox Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.31.4 Randox Saliva Drug and Alcohol Testing Product Portfolio
- 6.31.5 Randox Recent Developments
- 6.32 MediNat
- 6.32.1 MediNat Company Information
- 6.32.2 MediNat Business Overview
- 6.32.3 MediNat Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.32.4 MediNat Saliva Drug and Alcohol Testing Product Portfolio
- 6.32.5 MediNat Recent Developments
- 6.33 Clinical Labs
- 6.33.1 Clinical Labs Company Information
- 6.33.2 Clinical Labs Business Overview
- 6.33.3 Clinical Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.33.4 Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio
- 6.33.5 Clinical Labs Recent Developments
- 6.34 MHE
- 6.34.1 MHE Company Information
- 6.34.2 MHE Business Overview
- 6.34.3 MHE Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.34.4 MHE Saliva Drug and Alcohol Testing Product Portfolio
- 6.34.5 MHE Recent Developments
- 6.35 Awanui Labs
- 6.35.1 Awanui Labs Company Information
- 6.35.2 Awanui Labs Business Overview
- 6.35.3 Awanui Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.35.4 Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio
- 6.35.5 Awanui Labs Recent Developments
- 6.36 David Barber Occupational Health
- 6.36.1 David Barber Occupational Health Company Information
- 6.36.2 David Barber Occupational Health Business Overview
- 6.36.3 David Barber Occupational Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.36.4 David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio
- 6.36.5 David Barber Occupational Health Recent Developments
- 6.37 SYNLAB
- 6.37.1 SYNLAB Company Information
- 6.37.2 SYNLAB Business Overview
- 6.37.3 SYNLAB Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.37.4 SYNLAB Saliva Drug and Alcohol Testing Product Portfolio
- 6.37.5 SYNLAB Recent Developments
- 6.38 Test Smartly Labs
- 6.38.1 Test Smartly Labs Company Information
- 6.38.2 Test Smartly Labs Business Overview
- 6.38.3 Test Smartly Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.38.4 Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio
- 6.38.5 Test Smartly Labs Recent Developments
- 6.39 Cansford Laboratories
- 6.39.1 Cansford Laboratories Company Information
- 6.39.2 Cansford Laboratories Business Overview
- 6.39.3 Cansford Laboratories Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.39.4 Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio
- 6.39.5 Cansford Laboratories Recent Developments
- 6.40 Medigold Health
- 6.40.1 Medigold Health Company Information
- 6.40.2 Medigold Health Business Overview
- 6.40.3 Medigold Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.40.4 Medigold Health Saliva Drug and Alcohol Testing Product Portfolio
- 6.40.5 Medigold Health Recent Developments
- 6.41 PAM Group
- 6.42 Drugwise
- 6.43 Safework Health
- 6.44 Humanomics
- 6.45 CannAmm
- 6.46 Micro-Distributing
7 North America
- 7.1 North America Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 7.2 North America Saliva Drug and Alcohol Testing Market Size by Type
- 7.2.1 North America Saliva Drug and Alcohol Testing Market Size by Type (2021-2026)
- 7.2.2 North America Saliva Drug and Alcohol Testing Market Size by Type (2027-2032)
- 7.2.3 North America Saliva Drug and Alcohol Testing Market Share by Type (2021-2032)
- 7.3 North America Saliva Drug and Alcohol Testing Market Size by Application
- 7.3.1 North America Saliva Drug and Alcohol Testing Market Size by Application (2021-2026)
- 7.3.2 North America Saliva Drug and Alcohol Testing Market Size by Application (2027-2032)
- 7.3.3 North America Saliva Drug and Alcohol Testing Market Share by Application (2021-2032)
- 7.4 North America Saliva Drug and Alcohol Testing Market Size by Country
- 7.4.1 North America Saliva Drug and Alcohol Testing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 7.4.3 North America Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 7.4.4 North America Saliva Drug and Alcohol Testing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 8.2 Europe Saliva Drug and Alcohol Testing Market Size by Type
- 8.2.1 Europe Saliva Drug and Alcohol Testing Market Size by Type (2021-2026)
- 8.2.2 Europe Saliva Drug and Alcohol Testing Market Size by Type (2027-2032)
- 8.2.3 Europe Saliva Drug and Alcohol Testing Market Share by Type (2021-2032)
- 8.3 Europe Saliva Drug and Alcohol Testing Market Size by Application
- 8.3.1 Europe Saliva Drug and Alcohol Testing Market Size by Application (2021-2026)
- 8.3.2 Europe Saliva Drug and Alcohol Testing Market Size by Application (2027-2032)
- 8.3.3 Europe Saliva Drug and Alcohol Testing Market Share by Application (2021-2032)
- 8.4 Europe Saliva Drug and Alcohol Testing Market Size by Country
- 8.4.1 Europe Saliva Drug and Alcohol Testing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 8.4.3 Europe Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 8.4.4 Europe Saliva Drug and Alcohol Testing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 9.2 China Saliva Drug and Alcohol Testing Market Size by Type
- 9.2.1 China Saliva Drug and Alcohol Testing Market Size by Type (2021-2026)
- 9.2.2 China Saliva Drug and Alcohol Testing Market Size by Type (2027-2032)
- 9.2.3 China Saliva Drug and Alcohol Testing Market Share by Type (2021-2032)
- 9.3 China Saliva Drug and Alcohol Testing Market Size by Application
- 9.3.1 China Saliva Drug and Alcohol Testing Market Size by Application (2021-2026)
- 9.3.2 China Saliva Drug and Alcohol Testing Market Size by Application (2027-2032)
- 9.3.3 China Saliva Drug and Alcohol Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 10.2 Asia Saliva Drug and Alcohol Testing Market Size by Type
- 10.2.1 Asia Saliva Drug and Alcohol Testing Market Size by Type (2021-2026)
- 10.2.2 Asia Saliva Drug and Alcohol Testing Market Size by Type (2027-2032)
- 10.2.3 Asia Saliva Drug and Alcohol Testing Market Share by Type (2021-2032)
- 10.3 Asia Saliva Drug and Alcohol Testing Market Size by Application
- 10.3.1 Asia Saliva Drug and Alcohol Testing Market Size by Application (2021-2026)
- 10.3.2 Asia Saliva Drug and Alcohol Testing Market Size by Application (2027-2032)
- 10.3.3 Asia Saliva Drug and Alcohol Testing Market Share by Application (2021-2032)
- 10.4 Asia Saliva Drug and Alcohol Testing Market Size by Country
- 10.4.1 Asia Saliva Drug and Alcohol Testing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 10.4.3 Asia Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 10.4.4 Asia Saliva Drug and Alcohol Testing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Type
- 11.2.1 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Application
- 11.3.1 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country
- 11.4.1 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Saliva Drug and Alcohol Testing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst